MT ME Therapeutics Holdings Inc. Stock: price and management transactions · Canada · SEDISource id SEDI:me-therapeutics-holdings-inc CA · SEDI Mcap €26.4M Follow the ME Therapeutics Holdings Inc. share price and the full management transaction log of the company, a publicly traded company based in Canada. Shares are listed on the CA market, under the oversight of SEDI. Market capitalisation: €26.4m. The latest transaction was disclosed on 16 July 2026 (53 - Grant of warrants). Among the most active insiders: Priatel, John. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 July 2026
All Executives15 Thresholds0 Prospectus0 Other0
Declarations 15 total
● 3 - 10% Security Holder of Issuer, 4 - Director of Issuer · Executives · 16 Jul 2026
294,118 shares @ CA$2.00 1.41% mcap 37.1% of flow Warrants SEDI:4753264 ▲ 3 - 10% Security Holder of Issuer, 4 - Director of Issuer · Executives · 16 Jul 2026
294,118 shares @ CA$1.70 1.20% mcap 31.5% of flow Common Shares SEDI:4753262 Canonical exit: 14 Oct 2026 (T+90) ◇ 3 - 10% Security Holder of Issuer, 4 - Director of Issuer · Executives · 16 Jul 2026
250,000 shares @ CA$1.99 1.19% mcap 31.4% of flow Options SEDI:4753260 ◇ 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 16 Jul 2026
800,000 shares @ CA$1.99 3.81% mcap 100.0% of flow Options SEDI:4753258 ◇ 3 - 10% Security Holder of Issuer, 4 - Director of Issuer · Executives · 16 Jul 2026
250,000 shares @ CA$1.99 1.19% mcap 100.0% of flow Options SEDI:4753130 ◇ 5 - Senior Officer of Issuer · Executives · 16 Jul 2026
250,000 shares @ CA$1.99 1.19% mcap 100.0% of flow Options SEDI:4753122 ◇ 4 - Director of Issuer · Executives · 15 Jul 2026
250,000 shares @ CA$1.99 1.19% mcap 100.0% of flow Options SEDI:4753073 ◇ 5 - Senior Officer of Issuer · Executives · 16 Jul 2026
125,000 shares @ CA$1.99 0.60% mcap 100.0% of flow Options SEDI:4753050 ◇ 4 - Director of Issuer · Executives · 7 Jun 2026
250,000 shares Options SEDI:4751442 ◇ 5 - Senior Officer of Issuer · Executives · 31 Mar 2026
125,000 shares Options SEDI:4749461 ◇ 3 - 10% Security Holder of Issuer, 4 - Director of Issuer · Executives · 31 Mar 2026
250,000 shares Options SEDI:4748853 ◇ 5 - Senior Officer of Issuer · Executives · 31 Mar 2026
250,000 shares Options SEDI:4748848 ◇ 3 - 10% Security Holder of Issuer, 4 - Director of Issuer · Executives · 31 Mar 2026
250,000 shares Options SEDI:4748841 ◇ 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer · Executives · 31 Mar 2026
800,000 shares Options SEDI:4748818 ▲ 3 - 10% Security Holder of Issuer · Executives · 29 Jun 2026
200 shares @ CA$1.99 100.0% of flow Common Shares SEDI:4741838 Canonical exit: 27 Sept 2026 (T+90) 关于 ME Therapeutics Holdings Inc. ME Therapeutics Holdings Inc. 是一家在多伦多证券交易所上市的公司，专注于开发创新疗法。它致力于通过基于生物技术的方法增强医疗治疗。